Liposomal Doxorubicin Market was valued at USD 1211.8 million in 2021 and expected to grow with a significant growth rate CAGR of 6% between 2022 and 2028. Liposome Doxorubicin is wrapped in a fat cover called doxorubicin (Adriamycin) liposome containing chemotherapy drugs. Doxorubicin blocks an enzyme called topoisomerase 2 that requires cancer cells to divide […]
